Novavax to Report Third Quarter 2025 Financial Results on November 6, 2025

GAITHERSBURG, Md., Oct. 30, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced it will report its third quarter 2025 financial results and operational highlights at 8:30 a.m. Eastern Time (ET) on Thursday, November 6, 2025. Details of the event and replay are as follows:

Conference call details:

Date:

November 6, 2025

Time:

8:30 a.m. ET

URL to register phone:

Dial-in number:

(888) 880-3330 (U.S.) or

(+1) (646) 357-8766 (International)

Webcast:

ir.novavax.com/events

Replay details:

Date:

Available starting at 11:30 a.m. ET, November 6, 2025, until

11:59 p.m. ET, November 13, 2025

Dial-in number:

(800) 770-2030 (U.S.) or

(+1) (609) 800-9909 (International)

Passcode:

3585070#

Webcast:

ir.novavax.com/events, until December 5, 2025

About Novavax

Novavax, Inc. (Nasdaq: NVAX) tackles some of the world's most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including protein-based nanoparticles and its Matrix-M ® adjuvant. The Company's growth strategy seeks to optimize its existing partnerships and expand access to its proven technology platform via research and development innovation, organic portfolio expansion in infectious disease and beyond, and forging new partnerships and collaborations with other companies. Please visit novavax.com and LinkedIn for more information.

Contacts:

Investors

Luis Sanay, CFA

240-268-2022

ir@novavax.com

Media

Yvonne Sprow

844-264-8571

media@novavax.com

SOURCE Novavax, Inc.